The Non-Malignant Channel is supported with funding from Agios (Gold).
The Sickle Cell Disease Channel is supported with funding from Agios (Gold).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
BSH 2019 | Transfusion management of sickle cell disease: innovations, impact & next steps
Stella Chou, MD, University of Pennsylvania, Philadelphia, PA, speaks at the British Society for Haematology (BSH) 2019 Annual Meeting, held in Glasgow, UK. Dr Chou tells us about innovations in the transfusion management of patients with sickle cell disease, as well as the impact that these could have on patient care and quality of life. She highlights the hurdles remaining and the steps being taken to overcome them.
